Assessment of Some Cardiac Markers (CK-MB, Myoglobin and Troponin) in Iraqi Type-2 Diabetic Patients with Metabolic Syndrome

Cardiovascular diseases in the context of diabetes represent a main cause of morbidity and mortality with a two to three times higher risk of cardiovascular diseases in T2DM patients than in people without the condition (normoglycemia). The current study aimed to assess some Cardiac markers (CK-MB, myoglobin and troponin) in Iraqi type two diabetic patients with metabolic syndrome. The study was carried out on (60) patients with type-2 Diabetes mellitus who were divided into 2 groups: (30) subjects having metabolic syndromes and (30) subjects without metabolic syndromes. Venous blood samples were taken from patients who visited the Medical City Hospital-Baghdad during the period from November 2024 to January 2025.The results demonstrated highly significant differences between metabolic syndrome and without metabolic syndrome groups in regard to TG and HDL (p ≤ 0.001). In addition, there was a highly significant difference (p = 0.001) in CK-MB and Myoglobin levels between the two groups, and a significant variation was found in Troponin I levels between these groups (p = 0.003). We can conclude that a highly significant variation was found between individuals with type-2 diabetes having metabolic syndrome and subjects having no metabolic syndromes in regard to CK-MB, Troponin-1 and Myoglobin levels.